|
Publications
|
Highlighting research, discovery and innovation
CAMH Annual Report
Highlights from a year of achievements
-
 |
|
l-r: Dr. Shitij Kapur, Chair in imaging Technologies in Hu an Disease and Preclinical Models
|
Opened a new clinical trial unit that runs diverse clinical trials in addiction research in a modern, client-friendly trial
space.
- Was awarded two prestigious canada research chairs, bringing CAMH’s total to six. Dr. John Cairney received his first award
as a Canada Research Chair in Psychiatric Epidemiology, while Dr. Shitij Kapur’s Chair in Imaging Technologies in Human Disease
and Preclinical Models was renewed for five years.
- Discovered a new variant of the gene that causes RETT syndrome, a debilitating disease that leaves people profoundly disabled
and needing help with everyday living. The discovery has now been licensed as a test for the disorder and is available to
the public.
- Released the results of two long-term student surveys. The 2004 Canadian Campus Survey showed that rates of cigarette smoking
and use of hallucinogens among students on 40 Canadian university campuses have declined since 1998, but that 32 per cent
of students engage in harmful drinking and 30 per cent experience psychological stress. The 2005 Ontario Student Drug Use
Survey showed a significant drop in use of both legal and illegal drugs among Ontario students in grades 7 to 12, and that
student smoking is at its lowest rate since 1977. However, 14 per cent of students with a driver’s licence continue to drink
and drive, and 20 per cent smoke cannabis and drive.
- Showed how antipsychotic drugs begin to improve psychosis within hours or days of being administered, contrary to prevailing
assumptions of delayed onset of two to three weeks. This discovery, made possible by using brain imaging and clinical data,
is changing treatment and medication practices.
|
|
Centre for Addiction
